Amy Sullivan, Chief Financial Officer at IO Biotech, Inc. (IOBT), bought 10,250 shares at $0.83 ($9K) on 2024-12-23, disclosed to the SEC on 2024-12-23.
Open-market purchase of $9k IOBT by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.